Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to National Comprehensive Cancer Network
Related studies linked through entity extraction aliases.
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
- Status
- COMPLETED
- Phase
- NA
Expansion Trial for Axitinib In Head And Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL
- Status
- WITHDRAWN
- Phase
- PHASE1
Palliative and Oncology Care Model in Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry
- Status
- RECRUITING
- Phase
- N/A
Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations
- Status
- COMPLETED
- Phase
- PHASE2
Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Carfilzomib Plus Belinostat in Relapsed/Refractory NHL
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- NA
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Tivozanib As Maintenance Therapy In GYN
- Status
- TERMINATED
- Phase
- PHASE2
GSK1120212+GSK2141795 for Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trametinib With GSK2141795 in BRAF Wild-type Melanoma
- Status
- COMPLETED
- Phase
- PHASE2